Elk River Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$419K Sell
17,404
-368
-2% -$9.63K 0.07% 84
2026
Q1
$499K Hold
17,772
0.08% 74
2025
Q4
$443K Sell
17,772
-1,100
-6% -$27.7K 0.07% 76
2025
Q3
$481K Hold
18,872
0.08% 71
2025
Q2
$457K Hold
18,872
0.08% 72
2025
Q1
$478K Hold
18,872
0.09% 68
2024
Q4
$501K Sell
18,872
-2,200
-10% -$59.7K 0.09% 72
2024
Q3
$610K Hold
21,072
0.11% 63
2024
Q2
$590K Sell
21,072
-57
-0.3% -$1.57K 0.12% 59
2024
Q1
$586K Sell
21,129
-545
-3% -$15.1K 0.12% 62
2023
Q4
$624K Sell
21,674
-6,455
-23% -$195K 0.12% 68
2023
Q3
$933K Sell
28,129
-489
-2% -$17.3K 0.21% 52
2023
Q2
$1.05M Sell
28,618
-224
-0.8% -$8.72K 0.22% 50
2023
Q1
$1.18M Hold
28,842
0.27% 49
2022
Q4
$1.48M Sell
28,842
-300
-1% -$14.4K 0.36% 51
2022
Q3
$1.27M Sell
29,142
-215
-0.7% -$10.4K 0.34% 52
2022
Q2
$1.54M Hold
29,357
0.39% 55
2022
Q1
$1.52M Hold
29,357
0.33% 54
2021
Q4
$1.73M Buy
29,357
+315
+1% +$15.6K 0.39% 52
2021
Q3
$1.25M Hold
29,042
0.32% 54
2021
Q2
$1.14M Sell
29,042
-330
-1% -$12.8K 0.29% 60
2021
Q1
$1.06M Sell
29,372
-140
-0.5% -$4.97K 0.3% 59
2020
Q4
$1.09M Buy
+29,512
New +$1.08M 0.36% 60

Other funds holding PFE

Elk River Wealth Management's PFE Position: Q2 2026 in Review

Elk River Wealth Management reduced its Pfizer (PFE) stake by 2.1% in Q2 2026, selling an estimated $9.63K and leaving 17,404 shares worth $419K. The position accounts for 0.07% of the portfolio, ranked #84.

Elk River Wealth Management first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.73M in Q4 2021. 2,836 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Elk River Wealth Management held 17,404 shares of Pfizer worth $419K as of Q2 2026.
  • Elk River Wealth Management sold 368 Pfizer shares in Q2 2026, an estimated $9.63K.
  • Pfizer made up 0.07% of Elk River Wealth Management's portfolio in Q2 2026, its #84 holding.
  • Elk River Wealth Management first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
  • Elk River Wealth Management's Pfizer position peaked at $1.73M in Q4 2021.
  • 2,836 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Elk River Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.